Home/Pipeline/Cell Culture-Based Influenza Vaccine

Cell Culture-Based Influenza Vaccine

Influenza Prevention

ClinicalR&D

Key Facts

Indication
Influenza Prevention
Phase
Clinical
Status
R&D
Company

About Hualan Biological Engineering

Hualan Biological Engineering is a prominent, vertically integrated vaccine and blood product manufacturer in China, with a significant market share in influenza vaccines. The company leverages its established production capabilities and extensive distribution network to serve the domestic public health market. Its strategic focus includes expanding its vaccine portfolio, advancing its plasma fractionation business, and pursuing international market opportunities. As a publicly traded entity, it plays a key role in China's national immunization programs and biosecurity strategy.

View full company profile